Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
12/13/2012 | CA2838824A1 Modulation of pancreatic beta cell proliferation |
12/13/2012 | CA2838503A1 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same |
12/13/2012 | CA2838275A1 Methods for inhibiting muscle atrophy |
12/13/2012 | CA2838262A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk |
12/13/2012 | CA2837474A1 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases |
12/13/2012 | CA2837473A1 Human antigen binding proteins that bind to a complex comprising .beta.-klotho and an fgf receptor |
12/13/2012 | CA2836728A1 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof |
12/13/2012 | CA2836487A1 Novel compounds as modulators of gpr-119 |
12/12/2012 | EP2532656A1 Gpr119 agonist |
12/12/2012 | EP2532647A1 New co-crystals of agomelatin |
12/12/2012 | EP2532390A2 Pharmaceutical composition for obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
12/12/2012 | EP2532389A2 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
12/12/2012 | EP2532388A2 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
12/12/2012 | EP2532351A1 Agent for improving motility function |
12/12/2012 | EP2532254A1 Method for treatment of lacto-n-biose-containing solution |
12/12/2012 | EP2532251A1 Functional food and pharmaceutical compositions for anti-obesity comprising capsanthin and its fatty acylester derivatives having anti-adipogenic activity |
12/12/2012 | EP2531501A1 Apoptosis signal-regulating kinase 1 inhibitors |
12/12/2012 | EP2531485A2 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
12/12/2012 | EP2531261A2 Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus |
12/12/2012 | EP2531209A2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
12/12/2012 | CN202589978U Spherical container for dry ice diet pill |
12/12/2012 | CN1678734B Differentiation modulating agents and uses thereof |
12/12/2012 | CN1484650B Urocortin proteins and uses thereof |
12/12/2012 | CN102822154A Heteroarylcarboxylic acid ester derivative |
12/12/2012 | CN102822141A Salicylate fatty acid derivatives |
12/12/2012 | CN102821791A 透皮递送贴剂 Transdermal delivery patch |
12/12/2012 | CN102821774A Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease |
12/12/2012 | CN102821766A Oral formulation for dexlansoprazole |
12/12/2012 | CN102816832A Compound with alpha-glucosaccharase inhibitory activity in mulberry leaf and application of compound |
12/12/2012 | CN102816244A Fusion protein of exendin-4 peptide and human serum albumin (HSA) and preparation method thereof |
12/12/2012 | CN102816228A Single-chain insulin |
12/12/2012 | CN102816209A Chemokine-derived peptide, its expression gene and application thereof |
12/12/2012 | CN102816205A Beta-profilin 1, and fragment and applications thereof |
12/12/2012 | CN102816203A Substituted quinoline compound, and preparation method, medicine combination and application thereof |
12/12/2012 | CN102816189A Alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for immune adjuvant containing the same as active ingredient |
12/12/2012 | CN102816102A Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it |
12/12/2012 | CN102816081A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
12/12/2012 | CN102816079A New Co-crystals of Agomelatine, a Process for Their Preparation and Pharmaceutical Compositions Containing Them |
12/12/2012 | CN102813913A Sichuan blackberry extract composition |
12/12/2012 | CN102813889A Preparation method of chicken fattening powder |
12/12/2012 | CN102813870A Chinese herbal compound preparation used for treating alcoholism and gout and preparation method and application thereof |
12/12/2012 | CN102813840A Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy |
12/12/2012 | CN102813813A Natural medicinal and edible raw material composition for decreasing blood glucose and preparation method thereof |
12/12/2012 | CN102813808A Traditional Chinese medicine for treating yin and yang deficiency type diabetes |
12/12/2012 | CN102813807A Traditional Chinese medicine decoction for treating kidney and yin deficiency type diabetes |
12/12/2012 | CN102813806A Traditional Chinese medicine for treating lung heat and body fluid impairment type diabetes |
12/12/2012 | CN102813765A Method for preparing Zhixinkang preparation |
12/12/2012 | CN102813764A Chinese herbal medicinal composition used for reducing blood viscosity and blood lipid and preparation method thereof |
12/12/2012 | CN102813760A Natural medicinal and edible raw material composition for reducing blood fat and preparation method thereof |
12/12/2012 | CN102813755A Traditional Chinese medicine preparation for preventing and curing hyperlipemia and preparation method for traditional Chinese medicine preparation |
12/12/2012 | CN102813753A Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene |
12/12/2012 | CN102813736A Pure traditional Chinese medicine preparation used for rapidly reducing blood pressure |
12/12/2012 | CN102813733A Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity |
12/12/2012 | CN102813714A Health care product for adjuvant treatment of cardiovascular and cerebrovascular diseases and its preparation method |
12/12/2012 | CN102813708A Method for preparing Polygonum multiflorum traditional Chinese medicine granule decoction piece |
12/12/2012 | CN102813688A Anti-insulin resistance adenosine monophosphate-activated protein kinase agonist |
12/12/2012 | CN102813675A Compound potassium hydrogen phosphate medicine combination for injection |
12/12/2012 | CN102813666A Application of notoginsenoside R1 in medicine for preventing and treating neurologic and ophthalmic diseases |
12/12/2012 | CN102813656A Stable medicine composition of 5-methyltetrahydrofolic acid or salt thereof |
12/12/2012 | CN102813652A Repaglinide metformin hydrochloride tablet |
12/12/2012 | CN102813645A Control effect and mechanism of mangiferin on diabetic encephalopathy |
12/12/2012 | CN102813636A Nateglinide tablet and its preparation method |
12/12/2012 | CN102813252A Functional food and pharmaceutical compositions for anti-obesity comprising capsanthin and its fatty acylester derivatives having anti-adipogenic activity |
12/12/2012 | CN102813195A Blood glucose-lowering food containing okra and preparation method thereof |
12/12/2012 | CN102813112A Foodstuff for diabetic nephropathy |
12/12/2012 | CN102813062A Feed additive for preventing and treating broiler ascites syndrome |
12/12/2012 | CN102813031A Lipid-lowering and liver-protecting herbal tea |
12/12/2012 | CN102406661B Composite mineral substance crystal for regulating blood fat and blood sugar |
12/12/2012 | CN102319278B Monascus compound preparation capable of regulating pressure and lipid and improving arteriosclerosis, coronary heart disease and cerebral embolism |
12/12/2012 | CN102309462B Atorvastatin calcium tablet |
12/12/2012 | CN102133204B Preparation method of melbinum osmotic pump controlled release tablets |
12/12/2012 | CN102078356B Preparation method and applications of sugar-reducing effective part of chicory |
12/12/2012 | CN102026637B Lipoprotein lipase-activating compositions comprising benzene derivates |
12/12/2012 | CN102010512B Preparation method and application of water-soluble chitosan micro-particles |
12/12/2012 | CN101843308B 蜂胶软胶囊及其制备方法 Propolis and its preparation method |
12/12/2012 | CN101643432B New process for obtaining the crystalline form v of agomelatine |
12/12/2012 | CN101637259B Five flavored health wine and manufacturing method |
12/12/2012 | CN101631791B Substituted spirochromanone derivatives as ACC inhibitors |
12/12/2012 | CN101584793B Pure natural health-care four-Huai medicine |
12/12/2012 | CN101486677B 5HT2C receptor modulators |
12/12/2012 | CN101415716B Condensed imidazole derivatives as aldosterone synthase inhibitors |
12/12/2012 | CN101312746B Preparation containing iron(iii)-complexes and redox substances |
12/11/2012 | US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
12/11/2012 | US8329760 Pharmaceutical composition |
12/11/2012 | US8329742 Macrocyclic compounds useful as pharmaceuticals |
12/11/2012 | US8329727 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
12/11/2012 | US8329687 Pyridooxazepine derivative and use thereof |
12/11/2012 | US8329662 Prodrug of an ICE inhibitor |
12/11/2012 | US8329648 Methods for treating diabetes and reducing body weight |
12/11/2012 | US8329214 Process for producing fenofibrate tablets |
12/11/2012 | US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
12/11/2012 | CA2710464C Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof |
12/11/2012 | CA2579197C New double salts of (-)-hydroxycitric acid and a process for preparing the same |
12/11/2012 | CA2571722C Phenyl derivatives comprising an acetylene group |
12/11/2012 | CA2563461C Pyrazole phenyl derivatives as ppar activators |
12/11/2012 | CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
12/06/2012 | WO2012167251A1 Long-acting glp-1/glucagon receptor agonists |
12/06/2012 | WO2012166614A2 Thiocarbamate and sulfonamide hydroxamate inhibitors of insulin-degrading enzyme |
12/06/2012 | WO2012166420A1 Phosphoric acid salts of sitagliptin |
12/06/2012 | WO2012166008A1 Combination for treatment of diabetes mellitus |